Sunday 18 October 2026
Export HUMA’s income statement to Excel — free account
Humacyte, Inc.
HUMA Healthcare Biotechnology
Humacyte, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 million, up 30.2% from fiscal 2022. In the quarter to June 2026, revenue grew 34.9%, EPS grew 33.3%, free cash flow grew 17.9% and total debt rose 437.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.43
0.01
−2.27%
Follow HUMA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (534.42%) | (399.51%) | 164.78% | 114.92% |
+8 more TTM periods Free account |
|
| (68.16%) | (69.73%) | (32.12%) | (38.15%) | ||
ROIC |
(433.66%) | (268.02%) | (449.67%) | (2,258.85%) | |
Return on Tangible Assets |
(100.37%) | (146.96%) | (60.08%) | (110.43%) | |
Average Days of Receivables |
56.79 | 78.58 | 78.98 | 250.46 | |
Free Cash Flow per Share |
(0.42) | (0.52) | (0.67) | (0.67) | |
Free Cash Flow |
(97.56) | (102.38) | (105.93) | (106.40) | |
Capital Expenditures |
(0.37) | (0.83) | (0.88) | (0.91) | |
| Other line items | |||||
Cash ROIC |
(55.49%) | (82.80%) | (91.30%) | (253.99%) | |
Accounts Receivable Turnover |
5.86 | 4.37 | 6.56 | 2.83 | |
Accounts Payable Turnover |
2.34 | 2.18 | 1.96 | 0.23 | |
Inventory Turnover |
1.40 | 1.29 | 0.00 | 0.00 | |
Average Days of Payables |
120.32 | 160.00 | 203.30 | 1,806.14 | |
Days of Inventory on Hand |
202.17 | 312.33 | 511.23 | 3,474.20 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3,276.00% | 3,638.19% | 3,400.49% | 4,796.50% | |
Selling, General and Administrative Expense of Revenue |
1,470.20% | 1,535.96% | 1,529.49% | 1,972.44% | |
Share Based Compensation of Revenue |
504.90% | 517.66% | 478.56% | 571.42% | |
Interest Coverage |
(10.80) | (10.82) | (9.61) | (9.88) | |
Operating CF/Net income |
1.03 | 1.07 | 2.57 | 2.68 | |
Depreciation/Fixed assets |
0.48 | 0.44 | 0.40 | 0.37 | |
Capex/Depreciation |
(0.05) | (0.11) | (0.12) | (0.12) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(0.41) | (0.51) | (0.66) | (0.67) | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
0.17 | 0.41 | 0.43 | 0.58 |
Columns are period end dates